Anthera Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 22   

Articles published

ANTH 2.93 +0.04 (1.38%)
price chart
Anthera Pharmaceuticals Inc.: Anthera Pharmaceuticals Reports 2014 Second ...
HAYWARD, Calif., July 28, 2014 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and operational update for the second quarter ended June 30, 2014.
Related articles »  
Anthera Pharmaceuticals (ANTH) Releases Quarterly Earnings Results, Beats ...
Anthera Pharmaceuticals logo Anthera Pharmaceuticals (NASDAQ:ANTH) posted its quarterly earnings results on Monday. The company reported ($0.34) earnings per share for the quarter, beating the analysts' consensus estimate of ($0.49) by $0.15, AR ...
Anthera Pharmaceuticals Announces Acquisition of Sollpura� (liprotamase) for ...
HAYWARD, CA, USA I July 14, 2014 I Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH) today announced that it has acquired Sollpura (liprotamase), a novel investigational Pancreatic Enzyme Replacement Therapy ("PERT") from Eli Lilly and Company.
Anthera Pharmaceuticals Acquires Sollpur for Exocrine Pancreatic ...  Pharmaceutical Processing
Related articles »  
Anthera Pharmaceuticals Upgraded by Zacks to Outperform (ANTH)
Anthera Pharmaceuticals (NASDAQ:ANTH) last issued its quarterly earnings data on Tuesday, May 13th. The company reported ($0.39) earnings per share for the quarter, beating the analysts' consensus estimate of ($0.46) by $0.07.
The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly ...
Anthera Pharmaceuticals, Inc. (Nasdaq:ANTH-Free Report) is a biopharmaceutical company focussed on developing and commercializing therapeutics for the treatment of autoimmune diseases.
Related articles »  
Today's Stocks: Google Inc (NASDAQ:GOOGL), Google Inc (NASDAQ:GOOG ...
Anthera Pharmaceuticals Inc (NASDAQ:ANTH) traded 104,834.00 shares and its share price increased 0.32% to the closing price of $3.14.
Related articles »  
Intevac and Anthera Post Narrower Q2 Loss
Anthera Pharmaceuticals (ANTH), a biopharmaceutical company, reported a narrower-than-expected loss in the second quarter as interest expense decreased.
Anthera Acquires Sollpura from Eli Lilly
Anthera Pharmaceuticals, Inc. (ANTH) is a biopharmaceutical company focussed on developing and commercializing therapeutics for the treatment of autoimmune diseases.
Related articles »  
Sector Update: Health Care Stocks Swept Up in Biotech Sell-Off as Fed Sees ...
In company news, Anthera Pharmaceuticals Inc. ( ANTH ) fell Tuesday, with the drug-maker unable to sustain initial gains made after the company last night said it acquired development rights for liprotamase, an experimental pancreatic enzyme ...
Related articles »  
After-market Movers For July 14 (APOL, OPTT, CDXS, ANTH)
Apollo Education Group, Inc. (APOL: Quote) was down 6 percent to $27.85. The company disclosed that the the U.S. Department of Education intends to conduct an ordinary course program review of University of Phoenix's administration of federal student ...
Related articles »